Sources | Names Used |
---|---|
GDSC1000, FIMM | Bexarotene |
CTRPv2 | bexarotene |
PharmacoGx | Bexarotene |
Database | Identifier |
---|---|
Smiles: | CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C |
Inchikey: | NAVMQTYZDKMPEU-UHFFFAOYSA-N |
Pubchem: | 82146 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PUS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SURF4 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PDCD2L | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | C20orf194 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | WASL | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
mRNA | FAM105A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | UXS1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | TDRD9 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | KANK1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | RUFY1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |